Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Greenbrook Tms Inc GBNHF

Healthcare
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray) therapy in the United States for the treatment of depressive disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat... see more

Recent & Breaking News (OTCQB:GBNHF)

Greenbrook TMS Announces Dates for Its First Quarter 2021 Financial Results and Provides Corporate Update

Business Wire April 20, 2021

Greenbrook TMS Reports Fiscal 2020 Operational and Financial Results

Business Wire March 30, 2021

Greenbrook to Commence Trading on NASDAQ

Business Wire March 15, 2021

Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2020 Financial Results

Business Wire February 23, 2021

Greenbrook TMS Announces Completion of Share Consolidation in Connection With Proposed NASDAQ Listing

Business Wire February 1, 2021

Greenbrook TMS Included in First Psychedlics-Focused Exchange Traded Fund

Business Wire January 27, 2021

Greenbrook TMS Announces Director Resignation

Business Wire January 15, 2021

Greenbrook TMS Provides Update on Share Consolidation and Appointment of Stephan Roker to the Board

Business Wire January 12, 2021

Greenbrook TMS Closes US$30 Million Credit Facility With Oxford Finance LLC

Business Wire December 31, 2020

Greenbrook TMS to Participate at the 13th Annual LD Micro Main Event Conference

Business Wire December 7, 2020

Greenbrook TMS Announces Proposed Share Consolidation

Business Wire December 4, 2020

Greenbrook TMS Announces Participation in Upcoming Investor Conferences

Business Wire November 18, 2020

Greenbrook TMS Reports Third Quarter Financial Results With Continued Resilient Performance Through the COVID-19 Pandemic, Announces Spravato® Pilot Program and Provides Corporate Update

Business Wire November 10, 2020

Greenbrook TMS Announces Submission of Its Application to List on NASDAQ

Business Wire November 5, 2020

Greenbrook TMS Announces Dates for Its Third Quarter 2020 Financial Results

Business Wire October 20, 2020

Greenbrook TMS to Host Investor Webcast on September 24, 2020

Business Wire September 17, 2020

Greenbrook TMS Reaches Milestone with More Than 500,000 Treatments

Business Wire September 15, 2020

LD Micro -- 360 Companies Set to Present this Week

Accesswire August 31, 2020

LD Micro - Announces Preliminary List of Presenters for the LD-500

Accesswire August 5, 2020

Greenbrook TMS Reports Second Quarter Financial Results With Resilient Performance Through the COVID-19 Pandemic

Business Wire August 4, 2020